Metabolic Syndrome and Insulin Resistance in Sodium Valproate or Carbamazepine Monotherapy: A Case-control Study

Metabolic Syndrome and Insulin Resistance in Sodium Valproate or Carbamazepine Monotherapy: A Case-control Study

Background: Medications can increase the incidence rate of metabolic syndrome (MetS) and insulin resistance (IR). This study aimed to evaluate the effects of Carbamazepine (CBZ) or Valproate (VPA) as monotherapy on the development of MetS and IR in adult Iranian epileptic patients.Methods: In this o...

Full description

Bibliographic Details
Main Authors: Mahnaz Bayat, Nasrin Jalali, Maryam Poursadeghfard, Mohammad Hossein Dabbaghmanesh, Nahid Ashjazadeh
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2021-11-01
Series:Journal of Kerman University of Medical Sciences
Subjects:
cholesterol
cbz therapy
vpa-treated patients
Online Access:https://jkmu.kmu.ac.ir/article_91826_97358370ed05cb71b3acd1e6f8140296.pdf

Internet

https://jkmu.kmu.ac.ir/article_91826_97358370ed05cb71b3acd1e6f8140296.pdf

Similar Items